Latest Profit Growth News

Mach7 Technologies closes FY25 with solid recurring revenue growth, positive cash flow, and a refreshed leadership team focused on innovation and customer value.

Advanced Braking Technology Ltd (ABT) posted a robust FY25 with sales up 27% and underlying profits nearly doubling, driven by strong international demand and innovation milestones.

Compumedics has secured two significant four-year distribution agreements in China worth A$24.4 million, reinforcing its strategic foothold in Asia with committed annual growth of at least 10%.

Aumake Limited reports a robust 50% revenue increase to $39 million for FY25, driven by improving China-Australia trade relations. The company unveils a strategic pivot and corporate restructuring to sharpen its focus on profitable growth and brand incubation.

QuickFee Limited reports a record A$7.2 million quarterly revenue, driven by strong US and Australian growth, alongside positive underlying profitability and a major refinancing.

BKI Investment Company Limited reported a modest rise in revenue and operating profit for FY2025, alongside a 1% increase in dividends, supported by robust returns from key portfolio holdings.

Centrepoint Alliance has reported a robust FY25 with EBITDA rising 16% and net profit before tax jumping 30%, driven by strong adviser growth and strategic platform launches.

CAR Group announces a leadership transition with CFO William Elliott set to succeed long-serving CEO Cameron McIntyre, alongside an upbeat FY25 financial outlook signaling robust revenue and profit growth.

Rio Tinto reports a robust 13% year-on-year increase in copper equivalent production for Q2 2025, alongside record bauxite output and progress on key projects like Simandou and Oyu Tolgoi. The company maintains its 2025 guidance, signaling confidence in its diversified growth strategy.

Compumedics Limited has reported record sales orders and a return to profitability in FY25, setting the stage for robust growth in FY26 driven by US market traction and SaaS expansion.

Pacific Edge reports steady demand for its Cxbladder cancer diagnostic tests despite losing Medicare coverage and transitioning US customers to a new test. The company is advancing clinical evidence and a $21 million capital raise to support growth and regain coverage.

Stealth Group Holdings has secured exclusive distribution rights for major global consumer brands in Australia and New Zealand, aiming to accelerate revenue growth and expand its digital footprint.